<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2017-05-10" version="217">
<accession>Q06187</accession>
<accession>B2RAW1</accession>
<accession>Q32ML5</accession>
<name>BTK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase BTK</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Agammaglobulinemia tyrosine kinase</fullName>
<shortName>ATK</shortName>
</alternativeName>
<alternativeName>
<fullName>B-cell progenitor kinase</fullName>
<shortName>BPK</shortName>
</alternativeName>
<alternativeName>
<fullName>Bruton tyrosine kinase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BTK</name>
<name type="synonym">AGMX1</name>
<name type="synonym">ATK</name>
<name type="synonym">BPK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Nature" volume="361" first="226" last="233">
<title>The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.</title>
<authorList>
<person name="Vetrie D."/>
<person name="Vorechovsky I."/>
<person name="Sideras P."/>
<person name="Holland J."/>
<person name="Davies A."/>
<person name="Flinter F."/>
<person name="Hammarstroem L."/>
<person name="Kinnon C."/>
<person name="Levinsky R.J."/>
<person name="Bobrow M."/>
<person name="Smith C.I.E."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="8380905"/>
<dbReference type="DOI" id="10.1038/361226a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BTK-A)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Nature" volume="364" first="362" last="362">
<authorList>
<person name="Vetrie D."/>
<person name="Vorechovsky I."/>
<person name="Sideras P."/>
<person name="Holland J."/>
<person name="Davies A."/>
<person name="Flinter F."/>
<person name="Hammarstroem L."/>
<person name="Kinnon C."/>
<person name="Levinsky R.J."/>
<person name="Bobrow M."/>
<person name="Smith C.I.E."/>
<person name="Bentley D.R."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="9062" last="9066">
<title>Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.</title>
<authorList>
<person name="Ohta Y."/>
<person name="Haire R.N."/>
<person name="Litman R.T."/>
<person name="Fu S.M."/>
<person name="Nelson R.P."/>
<person name="Kratz J."/>
<person name="Kornfeld S.J."/>
<person name="la Morena M."/>
<person name="Good R.A."/>
<person name="Litman G.W."/>
</authorList>
<dbReference type="PubMed" id="8090769"/>
<dbReference type="DOI" id="10.1073/pnas.91.19.9062"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="Immunogenetics" volume="40" first="319" last="324">
<title>The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.</title>
<authorList>
<person name="Rohrer J."/>
<person name="Parolini O."/>
<person name="Belmont J.W."/>
<person name="Conley M.E."/>
</authorList>
<dbReference type="PubMed" id="7927535"/>
<dbReference type="DOI" id="10.1007/BF01246672"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1743" last="1749">
<title>Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.</title>
<authorList>
<person name="Hagemann T.L."/>
<person name="Chen Y."/>
<person name="Rosen F.S."/>
<person name="Kwan S.-P."/>
</authorList>
<dbReference type="PubMed" id="7880320"/>
<dbReference type="DOI" id="10.1093/hmg/3.10.1743"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS XLA SER-334; ARG-506; GLN-520; TRP-562 AND LYS-630</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Mamm. Genome" volume="6" first="334" last="338">
<title>Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci.</title>
<authorList>
<person name="Oeltjen J.C."/>
<person name="Liu X."/>
<person name="Lu J."/>
<person name="Allen R.C."/>
<person name="Muzny D.M."/>
<person name="Belmont J.W."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="7626884"/>
<dbReference type="DOI" id="10.1007/BF00364796"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BTK-A)</scope>
<source>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BTK-A)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="Cell" volume="72" first="279" last="290">
<title>Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.</title>
<authorList>
<person name="Tsukada S."/>
<person name="Saffran D.C."/>
<person name="Rawlings D.J."/>
<person name="Parolini O."/>
<person name="Allen R.C."/>
<person name="Klisak I."/>
<person name="Sparkes R.S."/>
<person name="Kubagawa H."/>
<person name="Mohandas T."/>
<person name="Quan S."/>
<person name="Belmont J.W."/>
<person name="Cooper M.D."/>
<person name="Conley M.E."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="8425221"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90667-F"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1-442</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-11" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Claeys D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-12 AND 323-332</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Biochim. Biophys. Acta" volume="1645" first="123" last="132">
<title>Identification of phosphorylation sites within the SH3 domains of Tec family tyrosine kinases.</title>
<authorList>
<person name="Nore B.F."/>
<person name="Mattsson P.T."/>
<person name="Antonsson P."/>
<person name="Backesjo C.-M."/>
<person name="Westlund A."/>
<person name="Lennartsson J."/>
<person name="Hansson H."/>
<person name="Low P."/>
<person name="Ronnstrand L."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="12573241"/>
<dbReference type="DOI" id="10.1016/S1570-9639(02)00524-1"/>
</citation>
<scope>PROTEIN SEQUENCE OF 219-235</scope>
<scope>PHOSPHORYLATION AT TYR-223</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1994" name="FEBS Lett." volume="346" first="165" last="170">
<title>An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.</title>
<authorList>
<person name="Duriez B."/>
<person name="Duquesnoy P."/>
<person name="Dastot F."/>
<person name="Bougneres P."/>
<person name="Amselem S."/>
<person name="Goossens M."/>
</authorList>
<dbReference type="PubMed" id="8013627"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)00457-9"/>
</citation>
<scope>INVOLVEMENT IN XLA-IGHD</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="FEBS Lett." volume="350" first="263" last="265">
<title>Tec homology (TH) adjacent to the PH domain.</title>
<authorList>
<person name="Vihinen M."/>
<person name="Nilsson L."/>
<person name="Smith C.I."/>
</authorList>
<dbReference type="PubMed" id="8070576"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)00783-7"/>
</citation>
<scope>DOMAIN PH</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1996" name="Immunity" volume="4" first="515" last="525">
<title>Regulation of Btk function by a major autophosphorylation site within the SH3 domain.</title>
<authorList>
<person name="Park H."/>
<person name="Wahl M.I."/>
<person name="Afar D.E."/>
<person name="Turck C.W."/>
<person name="Rawlings D.J."/>
<person name="Tam C."/>
<person name="Scharenberg A.M."/>
<person name="Kinet J.P."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="8630736"/>
<dbReference type="DOI" id="10.1016/S1074-7613(00)80417-3"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-223 AND TYR-551</scope>
<scope>MUTAGENESIS OF TYR-223</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="604" last="609">
<title>BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.</title>
<authorList>
<person name="Yang W."/>
<person name="Desiderio S."/>
</authorList>
<dbReference type="PubMed" id="9012831"/>
<dbReference type="DOI" id="10.1073/pnas.94.2.604"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF GTF2I</scope>
<scope>PHOSPHORYLATION AT TYR-223 AND TYR-551</scope>
<scope>MUTAGENESIS OF GLU-41; PRO-189; TYR-223; TRP-251; ARG-307 AND TYR-551</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="245" first="337" last="343">
<title>Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (Btk).</title>
<authorList>
<person name="Matsushita M."/>
<person name="Yamadori T."/>
<person name="Kato S."/>
<person name="Takemoto Y."/>
<person name="Inazawa J."/>
<person name="Baba Y."/>
<person name="Hashimoto S."/>
<person name="Sekine S."/>
<person name="Arai S."/>
<person name="Kunikata T."/>
<person name="Kurimoto M."/>
<person name="Kishimoto T."/>
<person name="Tsukada S."/>
</authorList>
<dbReference type="PubMed" id="9571151"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8420"/>
</citation>
<scope>MUTAGENESIS OF 251-TRP-TRP-252</scope>
<scope>INTERACTION WITH SH3BP5</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="10983" last="10989">
<title>Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells.</title>
<authorList>
<person name="Varnai P."/>
<person name="Rother K.I."/>
<person name="Balla T."/>
</authorList>
<dbReference type="PubMed" id="10196179"/>
<dbReference type="DOI" id="10.1074/jbc.274.16.10983"/>
</citation>
<scope>DOMAIN PH</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="6341" last="6346">
<title>Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.</title>
<authorList>
<person name="Yamadori T."/>
<person name="Baba Y."/>
<person name="Mastushita M."/>
<person name="Hashimoto S."/>
<person name="Kurosaki M."/>
<person name="Kurosaki T."/>
<person name="Kishimoto T."/>
<person name="Tsukada S."/>
</authorList>
<dbReference type="PubMed" id="10339589"/>
<dbReference type="DOI" id="10.1073/pnas.96.11.6341"/>
</citation>
<scope>INTERACTION WITH SH3BP5</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Eur. J. Immunol." volume="30" first="145" last="154">
<title>Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases.</title>
<authorList>
<person name="Nore B.F."/>
<person name="Vargas L."/>
<person name="Mohamed A.J."/>
<person name="Branden L.J."/>
<person name="Backesjo C.M."/>
<person name="Islam T.C."/>
<person name="Mattsson P.T."/>
<person name="Hultenby K."/>
<person name="Christensson B."/>
<person name="Smith C.I."/>
</authorList>
<dbReference type="PubMed" id="10602036"/>
<dbReference type="DOI" id="10.1002/1521-4141(200001)30:1&lt;145::AID-IMMU145>3.0.CO;2-0"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="40614" last="40619">
<title>Nucleocytoplasmic shuttling of Bruton's tyrosine kinase.</title>
<authorList>
<person name="Mohamed A.J."/>
<person name="Vargas L."/>
<person name="Nore B.F."/>
<person name="Backesjo C.M."/>
<person name="Christensson B."/>
<person name="Smith C.I."/>
</authorList>
<dbReference type="PubMed" id="11016936"/>
<dbReference type="DOI" id="10.1074/jbc.M006952200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="5692" last="5702">
<title>PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.</title>
<authorList>
<person name="Kang S.W."/>
<person name="Wahl M.I."/>
<person name="Chu J."/>
<person name="Kitaura J."/>
<person name="Kawakami Y."/>
<person name="Kato R.M."/>
<person name="Tabuchi R."/>
<person name="Tarakhovsky A."/>
<person name="Kawakami T."/>
<person name="Turck C.W."/>
<person name="Witte O.N."/>
<person name="Rawlings D.J."/>
</authorList>
<dbReference type="PubMed" id="11598012"/>
<dbReference type="DOI" id="10.1093/emboj/20.20.5692"/>
</citation>
<scope>PHOSPHORYLATION AT SER-180</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="47982" last="47992">
<title>Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling.</title>
<authorList>
<person name="Rodriguez R."/>
<person name="Matsuda M."/>
<person name="Perisic O."/>
<person name="Bravo J."/>
<person name="Paul A."/>
<person name="Jones N.P."/>
<person name="Light Y."/>
<person name="Swann K."/>
<person name="Williams R.L."/>
<person name="Katan M."/>
</authorList>
<dbReference type="PubMed" id="11606584"/>
<dbReference type="DOI" id="10.1074/jbc.M107577200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PLCG2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="Nat. Immunol." volume="2" first="939" last="946">
<title>Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.</title>
<authorList>
<person name="Liu W."/>
<person name="Quinto I."/>
<person name="Chen X."/>
<person name="Palmieri C."/>
<person name="Rabin R.L."/>
<person name="Schwartz O.M."/>
<person name="Nelson D.L."/>
<person name="Scala G."/>
</authorList>
<dbReference type="PubMed" id="11577348"/>
<dbReference type="DOI" id="10.1038/ni1001-939"/>
</citation>
<scope>INTERACTION WITH IBTK</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="9351" last="9357">
<title>Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx.</title>
<authorList>
<person name="Vargas L."/>
<person name="Nore B.F."/>
<person name="Berglof A."/>
<person name="Heinonen J.E."/>
<person name="Mattsson P.T."/>
<person name="Smith C.I."/>
<person name="Mohamed A.J."/>
</authorList>
<dbReference type="PubMed" id="11751885"/>
<dbReference type="DOI" id="10.1074/jbc.M108537200"/>
</citation>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH CAV1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="14180" last="14185">
<title>A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.</title>
<authorList>
<person name="Guo S."/>
<person name="Ferl G.Z."/>
<person name="Deora R."/>
<person name="Riedinger M."/>
<person name="Yin S."/>
<person name="Kerwin J.L."/>
<person name="Loo J.A."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="15375214"/>
<dbReference type="DOI" id="10.1073/pnas.0405878101"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-617 AND SER-623</scope>
<scope>MUTAGENESIS OF TYR-617</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="18201" last="18207">
<title>Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1.</title>
<authorList>
<person name="Yu L."/>
<person name="Mohamed A.J."/>
<person name="Vargas L."/>
<person name="Berglof A."/>
<person name="Finn G."/>
<person name="Lu K.P."/>
<person name="Smith C.I."/>
</authorList>
<dbReference type="PubMed" id="16644721"/>
<dbReference type="DOI" id="10.1074/jbc.M603090200"/>
</citation>
<scope>INTERACTION WITH PIN1</scope>
<scope>PHOSPHORYLATION AT SER-21 AND SER-115</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="J. Immunol." volume="176" first="3635" last="3641">
<title>Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production.</title>
<authorList>
<person name="Horwood N.J."/>
<person name="Page T.H."/>
<person name="McDaid J.P."/>
<person name="Palmer C.D."/>
<person name="Campbell J."/>
<person name="Mahon T."/>
<person name="Brennan F.M."/>
<person name="Webster D."/>
<person name="Foxwell B.M."/>
</authorList>
<dbReference type="PubMed" id="16517732"/>
<dbReference type="DOI" id="10.4049/jimmunol.176.6.3635"/>
</citation>
<scope>FUNCTION IN THE TLR PATHWAY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="4758" last="4768">
<title>Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.</title>
<authorList>
<person name="Rajaiya J."/>
<person name="Nixon J.C."/>
<person name="Ayers N."/>
<person name="Desgranges Z.P."/>
<person name="Roy A.L."/>
<person name="Webb C.F."/>
</authorList>
<dbReference type="PubMed" id="16738337"/>
<dbReference type="DOI" id="10.1128/MCB.02009-05"/>
</citation>
<scope>INTERACTION WITH GTF2I AND ARID3A</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="148" last="155">
<title>Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation.</title>
<authorList>
<person name="Mansell A."/>
<person name="Smith R."/>
<person name="Doyle S.L."/>
<person name="Gray P."/>
<person name="Fenner J.E."/>
<person name="Crack P.J."/>
<person name="Nicholson S.E."/>
<person name="Hilton D.J."/>
<person name="O'Neill L.A."/>
<person name="Hertzog P.J."/>
</authorList>
<dbReference type="PubMed" id="16415872"/>
<dbReference type="DOI" id="10.1038/ni1299"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TIRAP</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="36953" last="36960">
<title>Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase.</title>
<authorList>
<person name="Doyle S.L."/>
<person name="Jefferies C.A."/>
<person name="Feighery C."/>
<person name="O'Neill L.A."/>
</authorList>
<dbReference type="PubMed" id="17932028"/>
<dbReference type="DOI" id="10.1074/jbc.M707682200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TLR8 AND TLR9</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT TYR-223</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="BMC Immunol." volume="10" first="53" last="53">
<title>Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.</title>
<authorList>
<person name="Voss M."/>
<person name="Lettau M."/>
<person name="Janssen O."/>
</authorList>
<dbReference type="PubMed" id="19807924"/>
<dbReference type="DOI" id="10.1186/1471-2172-10-53"/>
</citation>
<scope>INTERACTION WITH FASLG</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1998" name="Biochem. Pharmacol." volume="56" first="683" last="691">
<title>Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis.</title>
<authorList>
<person name="Uckun F.M."/>
</authorList>
<dbReference type="PubMed" id="9751072"/>
<dbReference type="DOI" id="10.1016/S0006-2952(98)00122-1"/>
</citation>
<scope>REVIEW ON FUNCTION IN REGULATION OF APOPTOSIS</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Immunol. Rev." volume="228" first="58" last="73">
<title>Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.</title>
<authorList>
<person name="Mohamed A.J."/>
<person name="Yu L."/>
<person name="Backesjo C.M."/>
<person name="Vargas L."/>
<person name="Faryal R."/>
<person name="Aints A."/>
<person name="Christensson B."/>
<person name="Berglof A."/>
<person name="Vihinen M."/>
<person name="Nore B.F."/>
<person name="Smith C.I."/>
</authorList>
<dbReference type="PubMed" id="19290921"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2008.00741.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
<scope>REVIEW ON ENZYME REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-191; TYR-361 AND SER-659</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Genes Chromosomes Cancer" volume="52" first="961" last="975">
<title>A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.</title>
<authorList>
<person name="Eifert C."/>
<person name="Wang X."/>
<person name="Kokabee L."/>
<person name="Kourtidis A."/>
<person name="Jain R."/>
<person name="Gerdes M.J."/>
<person name="Conklin D.S."/>
</authorList>
<dbReference type="PubMed" id="23913792"/>
<dbReference type="DOI" id="10.1002/gcc.22091"/>
</citation>
<scope>ALTERNATIVE PROMOTER USAGE (ISOFORM BTK-C)</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-191; TYR-223 AND SER-604</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="3396" last="3404">
<title>Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.</title>
<authorList>
<person name="Hyvoenen M."/>
<person name="Saraste M."/>
</authorList>
<dbReference type="PubMed" id="9218782"/>
<dbReference type="DOI" id="10.1093/emboj/16.12.3396"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 2-170 IN COMPLEX WITH ZINC</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="2912" last="2924">
<title>Solution structure of the SH3 domain from Bruton's tyrosine kinase.</title>
<authorList>
<person name="Hansson H."/>
<person name="Mattsson P.T."/>
<person name="Allard P."/>
<person name="Haapaniemi P."/>
<person name="Vihinen M."/>
<person name="Smith C.I.E."/>
<person name="Haerd T."/>
</authorList>
<dbReference type="PubMed" id="9485443"/>
<dbReference type="DOI" id="10.1021/bi972409f"/>
</citation>
<scope>STRUCTURE BY NMR OF 212-275</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1999" name="Structure" volume="7" first="449" last="460">
<title>Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.</title>
<authorList>
<person name="Baraldi E."/>
<person name="Carugo K.D."/>
<person name="Hyvoenen M."/>
<person name="Surdo P.L."/>
<person name="Riley A.M."/>
<person name="Potter B.V.L."/>
<person name="O'Brien R."/>
<person name="Ladbury J.E."/>
<person name="Saraste M."/>
</authorList>
<dbReference type="PubMed" id="10196129"/>
<dbReference type="DOI" id="10.1016/S0969-2126(99)80057-4"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-170 IN COMPLEX WITH INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE AND ZINC</scope>
<scope>DOMAIN PH</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2000" name="J. Biomol. NMR" volume="16" first="303" last="312">
<title>Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.</title>
<authorList>
<person name="Tzeng S.R."/>
<person name="Lou Y.C."/>
<person name="Pai M.T."/>
<person name="Jain M.L."/>
<person name="Cheng J.W."/>
</authorList>
<dbReference type="PubMed" id="10826882"/>
<dbReference type="DOI" id="10.1023/A:1008376624863"/>
</citation>
<scope>STRUCTURE BY NMR OF 216-273</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="41435" last="41443">
<title>Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.</title>
<authorList>
<person name="Mao C."/>
<person name="Zhou M."/>
<person name="Uckun F.M."/>
</authorList>
<dbReference type="PubMed" id="11527964"/>
<dbReference type="DOI" id="10.1074/jbc.M104828200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 397-659</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2006" name="J. Biomol. NMR" volume="36" first="73" last="78">
<title>Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.</title>
<authorList>
<person name="Huang K.C."/>
<person name="Cheng H.T."/>
<person name="Pai M.T."/>
<person name="Tzeng S.R."/>
<person name="Cheng J.W."/>
</authorList>
<dbReference type="PubMed" id="16969585"/>
<dbReference type="DOI" id="10.1007/s10858-006-9064-3"/>
</citation>
<scope>STRUCTURE BY NMR OF 270-386</scope>
</reference>
<reference key="46">
<citation type="submission" date="2010-08" db="PDB data bank">
<title>A novel, specific Btk inhibitor antagonizes BCR and Fc[gamma]R signaling and suppresses inflammatory arthritis.</title>
<authorList>
<person name="Di Paolo J.A."/>
<person name="Huang T."/>
<person name="Balazs M."/>
<person name="Barbosa J."/>
<person name="Barck K.H."/>
<person name="Carano R.A.D."/>
<person name="Darrow J."/>
<person name="Davies D.R."/>
<person name="DeForge L.E."/>
<person name="Dennis G. Jr."/>
<person name="Diehl L."/>
<person name="Ferrando R."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 393-656 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="47">
<citation type="submission" date="2007-05" db="PDB data bank">
<title>Crystal structure of PH domain of Bruton's tyrosine kinase.</title>
<authorList>
<person name="Murayama K."/>
<person name="Kato-Murayama M."/>
<person name="Mishima C."/>
<person name="Shirouzu M."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS) OF 2-170 IN COMPLEX WITH INHIBITOR AND ZINC</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="Protein Sci." volume="19" first="429" last="439">
<title>Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.</title>
<authorList>
<person name="Marcotte D.J."/>
<person name="Liu Y.T."/>
<person name="Arduini R.M."/>
<person name="Hession C.A."/>
<person name="Miatkowski K."/>
<person name="Wildes C.P."/>
<person name="Cullen P.F."/>
<person name="Hong V."/>
<person name="Hopkins B.T."/>
<person name="Mertsching E."/>
<person name="Jenkins T.J."/>
<person name="Romanowski M.J."/>
<person name="Baker D.P."/>
<person name="Silvian L.F."/>
</authorList>
<dbReference type="PubMed" id="20052711"/>
<dbReference type="DOI" id="10.1002/pro.321"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 382-659 IN COMPLEX WITH INHIBITOR DASATINIB</scope>
</reference>
<reference key="49">
<citation type="submission" date="2010-09" db="PDB data bank">
<title>A novel, specific BTK inhibitor antagonizes BCR and FcgR signaling and suppresses inflammatory arthritis.</title>
<authorList>
<person name="Di Paolo J."/>
<person name="Huang T."/>
<person name="Balazs M."/>
<person name="Barbosa J."/>
<person name="Barck K.H."/>
<person name="Bravo B."/>
<person name="Carano R.A.D."/>
<person name="Darrow J."/>
<person name="Davies D.R."/>
<person name="DeForge L.E."/>
<person name="Diehl L."/>
<person name="Ferrando R."/>
<person name="Gallion S.L."/>
<person name="Gianetti A.M."/>
<person name="Gribling P."/>
<person name="Hurez V."/>
<person name="Hymowitz S.G."/>
<person name="Jones R."/>
<person name="Kropf J.E."/>
<person name="Lee W.P."/>
<person name="Maciejewski P.M."/>
<person name="Mitchell S.A."/>
<person name="Rong H."/>
<person name="Staker B.L."/>
<person name="Whitney J.A."/>
<person name="Yeh S."/>
<person name="Young W."/>
<person name="Yu C."/>
<person name="Zhang J."/>
<person name="Reif K."/>
<person name="Currie K.S."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 393-659</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="Protein Sci." volume="20" first="428" last="436">
<title>Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures.</title>
<authorList>
<person name="Kuglstatter A."/>
<person name="Wong A."/>
<person name="Tsing S."/>
<person name="Lee S.W."/>
<person name="Lou Y."/>
<person name="Villasenor A.G."/>
<person name="Bradshaw J.M."/>
<person name="Shaw D."/>
<person name="Barnett J.W."/>
<person name="Browner M.F."/>
</authorList>
<dbReference type="PubMed" id="21280133"/>
<dbReference type="DOI" id="10.1002/pro.575"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 387-659 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="160" last="165">
<title>BTKbase, mutation database for X-linked agammaglobulinemia (XLA).</title>
<authorList>
<person name="Vihinen M."/>
<person name="Iwata T."/>
<person name="Kinnon C."/>
<person name="Kwan S.-P."/>
<person name="Ochs H.D."/>
<person name="Vorechovsky I."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="8594569"/>
<dbReference type="DOI" id="10.1093/nar/24.1.160"/>
</citation>
<scope>REVIEW ON VARIANTS XLA</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="166" last="171">
<title>BTKbase, mutation database for X-linked agammaglobulinemia (XLA).</title>
<authorList>
<person name="Vihinen M."/>
<person name="Belohradsky B.H."/>
<person name="Haire R.N."/>
<person name="Holinski-Feder E."/>
<person name="Kwan S.-P."/>
<person name="Lappalainen I."/>
<person name="Lehvaeslaiho H."/>
<person name="Lester T."/>
<person name="Meindl A."/>
<person name="Ochs H.D."/>
<person name="Ollila J."/>
<person name="Vorechovsky I."/>
<person name="Weiss M."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="9016530"/>
<dbReference type="DOI" id="10.1093/nar/25.1.166"/>
</citation>
<scope>REVIEW ON VARIANTS XLA</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="79" last="83">
<title>Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.</title>
<authorList>
<person name="Bradley L.A.D."/>
<person name="Sweatman A.K."/>
<person name="Lovering R.C."/>
<person name="Jones A.M."/>
<person name="Morgan G."/>
<person name="Levinsky R.J."/>
<person name="Kinnon C."/>
</authorList>
<dbReference type="PubMed" id="8162056"/>
<dbReference type="DOI" id="10.1093/hmg/3.1.79"/>
</citation>
<scope>VARIANTS XLA TRP-288; GLY-307; ASP-607 AND SER-VAL-PHE-SER-SER-THR-ARG-103 INS</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="161" last="166">
<title>Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.</title>
<authorList>
<person name="de Weers M."/>
<person name="Mensink R.G.J."/>
<person name="Kraakman M.E.M."/>
<person name="Schuurman R.K.B."/>
<person name="Hendriks R.W."/>
</authorList>
<dbReference type="PubMed" id="8162018"/>
<dbReference type="DOI" id="10.1093/hmg/3.1.161"/>
</citation>
<scope>VARIANTS XLA HIS-28 AND TRP-288</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1751" last="1756">
<title>Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.</title>
<authorList>
<person name="Conley M.E."/>
<person name="Fitch-Hilgenberg M.E."/>
<person name="Cleveland J.L."/>
<person name="Parolini O."/>
<person name="Rohrer J."/>
</authorList>
<dbReference type="PubMed" id="7849697"/>
<dbReference type="DOI" id="10.1093/hmg/3.10.1751"/>
</citation>
<scope>VARIANTS XLA ASP-113; CYS-361; GLN-520; PRO-542; TRP-562; LYS-630 AND PRO-652</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1899" last="1900">
<title>Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.</title>
<authorList>
<person name="Zhu Q."/>
<person name="Zhang M."/>
<person name="Winkelstein J."/>
<person name="Chen S.-H."/>
<person name="Ochs H.D."/>
</authorList>
<dbReference type="PubMed" id="7849721"/>
<dbReference type="DOI" id="10.1093/hmg/3.10.1899"/>
</citation>
<scope>VARIANTS XLA HIS-28; PRO-33; PRO-408; GLY-589; ASP-613 AND 260-GLN--GLU-280 DEL</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="12803" last="12807">
<title>Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.</title>
<authorList>
<person name="Vihinen M."/>
<person name="Vetrie D."/>
<person name="Maniar H.S."/>
<person name="Ochs H.D."/>
<person name="Zhu Q."/>
<person name="Vorechovsky I."/>
<person name="Webster A.D.B."/>
<person name="Notarangelo L.D."/>
<person name="Nilsson L."/>
<person name="Sowadski J.M."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="7809124"/>
<dbReference type="DOI" id="10.1073/pnas.91.26.12803"/>
</citation>
<scope>VARIANTS XLA GLU-430; GLN-520; GLN-525; PRO-562; VAL-582; GLY-589; GLU-594 AND ASP-613</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1995" name="Biochemistry" volume="34" first="1475" last="1481">
<title>Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia.</title>
<authorList>
<person name="Vihinen M."/>
<person name="Zvelebil J.J.M."/>
<person name="Zhu Q."/>
<person name="Brooimans R.A."/>
<person name="Ochs H.D."/>
<person name="Zegers B.J.M."/>
<person name="Nilsson L."/>
<person name="Waterfield M.D."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="7849006"/>
<dbReference type="DOI" id="10.1021/bi00005a002"/>
</citation>
<scope>VARIANT XLA PHE-64</scope>
<scope>CHARACTERIZATION OF OTHER XLA VARIANTS</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="51" last="58">
<title>DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.</title>
<authorList>
<person name="Vorechovsky I."/>
<person name="Vihinen M."/>
<person name="de Saint Basile G."/>
<person name="Honsova S."/>
<person name="Hammarstroem L."/>
<person name="Mueller S."/>
<person name="Nilsson L."/>
<person name="Fischer A."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="7711734"/>
<dbReference type="DOI" id="10.1093/hmg/4.1.51"/>
</citation>
<scope>VARIANTS XLA SER-25; TRP-288; MET-370; VAL-509; PRO-525; LYS-526; TRP-562; VAL-582 AND ARG-594</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="693" last="700">
<title>Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).</title>
<authorList>
<person name="Jin H."/>
<person name="Webster A.D.B."/>
<person name="Vihinen M."/>
<person name="Sideras P."/>
<person name="Vorechovsky I."/>
<person name="Hammarstroem L."/>
<person name="Bernatowska-Matuszkiewicz E."/>
<person name="Smith C.I.E."/>
<person name="Bobrow M."/>
<person name="Vetrie D."/>
</authorList>
<dbReference type="PubMed" id="7633420"/>
<dbReference type="DOI" id="10.1093/hmg/4.4.693"/>
</citation>
<scope>VARIANTS XLA LYS-567; LEU-587 AND HIS-641</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="755" last="757">
<title>Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot.</title>
<authorList>
<person name="Gaspar H.B."/>
<person name="Bradley L.A.D."/>
<person name="Katz F."/>
<person name="Lovering R.C."/>
<person name="Roifman C.M."/>
<person name="Morgan G."/>
<person name="Levinsky R.J."/>
<person name="Kinnon C."/>
</authorList>
<dbReference type="PubMed" id="7633429"/>
<dbReference type="DOI" id="10.1093/hmg/4.4.755"/>
</citation>
<scope>VARIANTS XLA PRO-33; GLY-302 DEL; GLN-520 AND CYS-641</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="2403" last="2405">
<title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase.</title>
<authorList>
<person name="Vorechovsky I."/>
<person name="Luo L."/>
<person name="de Saint Basile G."/>
<person name="Hammarstroem L."/>
<person name="Webster A.D.B."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="8634718"/>
<dbReference type="DOI" id="10.1093/hmg/4.12.2403"/>
</citation>
<scope>VARIANTS XLA ASN-429 AND ARG-477</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="296" last="302">
<title>Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.</title>
<authorList>
<person name="Hagemann T.L."/>
<person name="Rosen F.S."/>
<person name="Kwan S.-P."/>
</authorList>
<dbReference type="PubMed" id="7627183"/>
<dbReference type="DOI" id="10.1002/humu.1380050405"/>
</citation>
<scope>VARIANTS XLA GLU-302 AND ASP-476</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1995" name="J. Med. Genet." volume="32" first="77" last="79">
<title>A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia.</title>
<authorList>
<person name="Ohashi Y."/>
<person name="Tsuchiya S."/>
<person name="Konno T."/>
</authorList>
<dbReference type="PubMed" id="7897635"/>
<dbReference type="DOI" id="10.1136/jmg.32.1.77"/>
</citation>
<scope>VARIANT XLA PHE-358</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1996" name="Am. J. Med. Genet." volume="63" first="318" last="322">
<title>Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.</title>
<authorList>
<person name="Schuster V."/>
<person name="Seidenspinner S."/>
<person name="Kreth H.W."/>
</authorList>
<dbReference type="PubMed" id="8723128"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19960503)63:1&lt;318::AID-AJMG53>3.0.CO;2-N"/>
</citation>
<scope>VARIANT XLA PRO-295</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1996" name="Blood" volume="88" first="561" last="573">
<title>Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.</title>
<authorList>
<person name="Hashimoto S."/>
<person name="Tsukada S."/>
<person name="Matsushita M."/>
<person name="Miyawaki T."/>
<person name="Niida Y."/>
<person name="Yachie A."/>
<person name="Kobayashi S."/>
<person name="Iwata T."/>
<person name="Hayakawa H."/>
<person name="Matsuoka H."/>
<person name="Tsuge I."/>
<person name="Yamadori T."/>
<person name="Kunikata T."/>
<person name="Arai S."/>
<person name="Yoshizaki K."/>
<person name="Taniguchi N."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="8695804"/>
</citation>
<scope>VARIANTS XLA ARG-12; PRO-28; GLU-302; TRP-502; HIS-521; TYR-633 AND SER-644</scope>
</reference>
<reference key="67">
<citation type="journal article" date="1996" name="Hum. Genet." volume="97" first="424" last="430">
<title>Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan.</title>
<authorList>
<person name="Kobayashi S."/>
<person name="Iwata T."/>
<person name="Saito M."/>
<person name="Iwasaki R."/>
<person name="Matsumoto H."/>
<person name="Naritaka S."/>
<person name="Kono Y."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="8834236"/>
<dbReference type="DOI" id="10.1007/BF02267060"/>
</citation>
<scope>VARIANTS XLA TRP-288; LYS-544 AND PRO-592</scope>
</reference>
<reference key="68">
<citation type="journal article" date="1997" name="FEBS Lett." volume="413" first="205" last="210">
<title>Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.</title>
<authorList>
<person name="Vihinen M."/>
<person name="Nore B."/>
<person name="Mattsson P.T."/>
<person name="Backesj C.-M."/>
<person name="Nars M."/>
<person name="Koutaniemi S."/>
<person name="Watanabe C."/>
<person name="Lester T."/>
<person name="Jones A.M."/>
<person name="Ochs H.D."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="9280283"/>
<dbReference type="DOI" id="10.1016/S0014-5793(97)00912-5"/>
</citation>
<scope>VARIANTS XLA SER-154 AND ARG-155</scope>
</reference>
<reference key="69">
<citation type="journal article" date="1997" name="Mol. Med." volume="3" first="477" last="485">
<title>Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.</title>
<authorList>
<person name="Saha B.K."/>
<person name="Curtis S.K."/>
<person name="Vogler L.B."/>
<person name="Vihinen M."/>
</authorList>
<dbReference type="PubMed" id="9260159"/>
</citation>
<scope>VARIANTS XLA</scope>
</reference>
<reference key="70">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="62" first="1034" last="1043">
<title>Mutations in btk in patients with presumed X-linked agammaglobulinemia.</title>
<authorList>
<person name="Conley M.E."/>
<person name="Mathias D."/>
<person name="Treadaway J."/>
<person name="Minegishi Y."/>
<person name="Rohrer J."/>
</authorList>
<dbReference type="PubMed" id="9545398"/>
<dbReference type="DOI" id="10.1086/301828"/>
</citation>
<scope>VARIANTS XLA GLN-288; THR-307; ARG-430; ASP-445; GLY-525; PHE-535; LEU-563 AND PRO-622</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1998" name="Pediatrics" volume="101" first="276" last="284">
<title>Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.</title>
<authorList>
<person name="Holinski-Feder E."/>
<person name="Weiss M."/>
<person name="Brandau O."/>
<person name="Jedele K.B."/>
<person name="Nore B."/>
<person name="Baeckesjoe C.-M."/>
<person name="Vihinen M."/>
<person name="Hubbard S.R."/>
<person name="Belohradsky B.H."/>
<person name="Smith C.I.E."/>
<person name="Meindl A."/>
</authorList>
<dbReference type="PubMed" id="9445504"/>
<dbReference type="DOI" id="10.1542/peds.101.2.276"/>
</citation>
<scope>VARIANTS XLA GLU-19; HIS-28; ASN-61; PRO-117; HIS-127; ARG-155; PRO-295; PHE-369; GLY-372; ARG-414; TYR-506; GLY-521; GLN-525; SER-559; TRP-562; GLU-594; THR-619; GLY-626 AND HIS-641</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="280" last="285">
<title>Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia.</title>
<authorList>
<person name="Vihinen M."/>
<person name="Kwan S.-P."/>
<person name="Lester T."/>
<person name="Ochs H.D."/>
<person name="Resnick I."/>
<person name="Vaeliaho J."/>
<person name="Conley M.E."/>
<person name="Smith C.I.E."/>
</authorList>
<dbReference type="PubMed" id="10220140"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)13:4&lt;280::AID-HUMU3>3.0.CO;2-L"/>
</citation>
<scope>VARIANTS XLA</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2000" name="Am. J. Med. Genet." volume="90" first="229" last="232">
<title>Twin carriers of X-linked agammaglobulinemia (XLA) due to germline mutation in the Btk gene.</title>
<authorList>
<person name="Curtis S.K."/>
<person name="Hebert M.D."/>
<person name="Saha B.K."/>
</authorList>
<dbReference type="PubMed" id="10678660"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(20000131)90:3&lt;229::AID-AJMG8>3.0.CO;2-Q"/>
</citation>
<scope>VARIANT XLA PRO-562</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="117" last="117">
<title>Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.</title>
<authorList>
<person name="Orlandi P."/>
<person name="Ritis K."/>
<person name="Moschese V."/>
<person name="Angelini F."/>
<person name="Arvanitidis K."/>
<person name="Speletas M."/>
<person name="Sideras P."/>
<person name="Plebani A."/>
<person name="Rossi P."/>
</authorList>
<dbReference type="PubMed" id="10612838"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200001)15:1&lt;117::AID-HUMU26>3.0.CO;2-H"/>
</citation>
<scope>VARIANTS XLA SER-39; PRO-512; GLN-512; GLY-544; TYR-578 AND LYS-589</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LYS-82 AND LYS-190</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2014" name="N. Engl. J. Med." volume="370" first="2286" last="2294">
<title>Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.</title>
<authorList>
<person name="Woyach J.A."/>
<person name="Furman R.R."/>
<person name="Liu T.M."/>
<person name="Ozer H.G."/>
<person name="Zapatka M."/>
<person name="Ruppert A.S."/>
<person name="Xue L."/>
<person name="Li D.H."/>
<person name="Steggerda S.M."/>
<person name="Versele M."/>
<person name="Dave S.S."/>
<person name="Zhang J."/>
<person name="Yilmaz A.S."/>
<person name="Jaglowski S.M."/>
<person name="Blum K.A."/>
<person name="Lozanski A."/>
<person name="Lozanski G."/>
<person name="James D.F."/>
<person name="Barrientos J.C."/>
<person name="Lichter P."/>
<person name="Stilgenbauer S."/>
<person name="Buggy J.J."/>
<person name="Chang B.Y."/>
<person name="Johnson A.J."/>
<person name="Byrd J.C."/>
</authorList>
<dbReference type="PubMed" id="24869598"/>
<dbReference type="DOI" id="10.1056/NEJMoa1400029"/>
</citation>
<scope>VARIANT SER-481</scope>
<scope>CHARACTERIZATION OF VARIANT SER-481</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="N. Engl. J. Med." volume="370" first="2352" last="2354">
<title>Ibrutinib resistance in chronic lymphocytic leukemia.</title>
<authorList>
<person name="Furman R.R."/>
<person name="Cheng S."/>
<person name="Lu P."/>
<person name="Setty M."/>
<person name="Perez A.R."/>
<person name="Perez A.R."/>
<person name="Guo A."/>
<person name="Racchumi J."/>
<person name="Xu G."/>
<person name="Wu H."/>
<person name="Ma J."/>
<person name="Steggerda S.M."/>
<person name="Coleman M."/>
<person name="Leslie C."/>
<person name="Wang Y.L."/>
</authorList>
<dbReference type="PubMed" id="24869597"/>
<dbReference type="DOI" id="10.1056/NEJMc1402716"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT SER-481</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2015" name="Leukemia" volume="29" first="895" last="900">
<title>Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors.</title>
<authorList>
<person name="Cheng S."/>
<person name="Guo A."/>
<person name="Lu P."/>
<person name="Ma J."/>
<person name="Coleman M."/>
<person name="Wang Y.L."/>
</authorList>
<dbReference type="PubMed" id="25189416"/>
<dbReference type="DOI" id="10.1038/leu.2014.263"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT SER-481</scope>
</reference>
<comment type="function">
<text evidence="30 34 35 37 39 66">Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling. Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members. PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK. BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways. Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway. The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells. Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation. BTK plays also a critical role in transcription regulation. Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes. BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B. Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR. GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression. ARID3A and NFAT are other transcriptional target of BTK. BTK is required for the formation of functional ARID3A DNA-binding complexes. There is however no evidence that BTK itself binds directly to DNA. BTK has a dual role in the regulation of apoptosis.</text>
</comment>
<comment type="catalytic activity">
<text evidence="21">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text>Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="25 28 29 31 34 36 39 61">Activated by phosphorylation. In primary B lymphocytes, is almost always non-phosphorylated and is thus catalytically inactive. Stimulation of TLR8 and TLR9 causes BTK activation. As a negative feedback mechanism to fine-tune BCR signaling, activated PRKCB down-modulates BTK function via direct phosphorylation of BTK at Ser-180, resulting in translocation of BTK back to the cytoplasmic fraction. PIN1, SH3BP5, and IBTK were also identified as BTK activity inhibitors. Interaction with CAV1 leads to dramatic down-regulation of the kinase activity of BTK. LFM-13A is a specific inhibitor of BTK. Dasatinib, a cancer drug acting as a tyrosine kinase inhibitor, also blocks BTK activity.</text>
</comment>
<comment type="subunit">
<text evidence="22 25 28 31 36 37 39 40 41 42 68 73 75 76">Binds GTF2I through the PH domain. Interacts with SH3BP5 via the SH3 domain. Interacts with IBTK via its PH domain. Interacts with ARID3A, CAV1, FASLG, PIN1, TLR8 and TLR9.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-624835"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-5458244">
<id>Q99856</id>
<label>ARID3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-2623522">
<id>Q8WV28</id>
<label>BLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-359622">
<id>P78347</id>
<label>GTF2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-3932027">
<id>P21145</id>
<label>MAL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-10172134">
<id>A4D127</id>
<label>MEOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-374762">
<id>Q04759</id>
<label>PRKCQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-624860">
<id>O60239</id>
<label>SH3BP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-624835"/>
<interactant intactId="EBI-346375">
<id>P42768</id>
<label>WAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>In steady state, BTK is predominantly cytosolic. Following B-cell receptor (BCR) engagement by antigen, translocates to the plasma membrane through its PH domain. Plasma membrane localization is a critical step in the activation of BTK. A fraction of BTK also shuttles between the nucleus and the cytoplasm, and nuclear export is mediated by the nuclear export receptor CRM1.</text>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<isoform>
<id>Q06187-1</id>
<name>BTK-A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q06187-2</id>
<name>BTK-C</name>
<sequence type="described" ref="VSP_053838"/>
<text>Produced by alternative promoter usage. Predominant form in many tumor cells where it may function as an anti-apoptotic cell survival factor.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Predominantly expressed in B-lymphocytes.</text>
</comment>
<comment type="domain">
<text evidence="22 23 31 57">The PH domain mediates the binding to inositol polyphosphate and phosphoinositides, leading to its targeting to the plasma membrane. It is extended in the BTK kinase family by a region designated the TH (Tec homology) domain, which consists of about 80 residues preceding the SH3 domain.</text>
</comment>
<comment type="PTM">
<text evidence="29 32 33 36 39 61 66">Following B-cell receptor (BCR) engagement, translocates to the plasma membrane where it gets phosphorylated at Tyr-551 by LYN and SYK. Phosphorylation at Tyr-551 is followed by autophosphorylation of Tyr-223 which may create a docking site for a SH2 containing protein. Phosphorylation at Ser-180 by PRKCB, leads in translocation of BTK back to the cytoplasmic fraction. Phosphorylation at Ser-21 and Ser-115 creates a binding site for PIN1 at these Ser-Pro motifs, and promotes it's recruitment.</text>
</comment>
<comment type="disease" evidence="24 26 27 46 47 48 49 50 51 52 53 54 55 56 58 59 60 62 63 64 65 67 69 70 71 72">
<disease id="DI-02427">
<name>X-linked agammaglobulinemia</name>
<acronym>XLA</acronym>
<description>Humoral immunodeficiency disease which results in developmental defects in the maturation pathway of B-cells. Affected boys have normal levels of pre-B-cells in their bone marrow but virtually no circulating mature B-lymphocytes. This results in a lack of immunoglobulins of all classes and leads to recurrent bacterial infections like otitis, conjunctivitis, dermatitis, sinusitis in the first few years of life, or even some patients present overwhelming sepsis or meningitis, resulting in death in a few hours. Treatment in most cases is by infusion of intravenous immunoglobulin.</description>
<dbReference type="MIM" id="300755"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="56">
<disease id="DI-02446">
<name>X-linked hypogammaglobulinemia and isolated growth hormone deficiency</name>
<acronym>XLA-IGHD</acronym>
<description>In rare cases XLA is inherited together with isolated growth hormone deficiency (IGHD).</description>
<dbReference type="MIM" id="307200"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the protein kinase superfamily. Tyr protein kinase family. TEC subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BTKID851chXq22.html"/>
</comment>
<comment type="online information" name="BTKbase">
<link uri="http://structure.bmc.lu.se/idbase/BTKbase/"/>
<text>BTK mutation db</text>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="X58957">
<property type="protein sequence ID" value="CAA41728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U10087">
<property type="protein sequence ID" value="AAB60639.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U10084">
<property type="protein sequence ID" value="AAB60639.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U10085">
<property type="protein sequence ID" value="AAB60639.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U10086">
<property type="protein sequence ID" value="AAB60639.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31572">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31557">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31558">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31559">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31561">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31563">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31564">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31565">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31566">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31567">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31568">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31569">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31570">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L31571">
<property type="protein sequence ID" value="AAA61479.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13433">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13410">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13412">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13413">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13414">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13415">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13416">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13417">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13422">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13423">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13424">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13425">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13427">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13428">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13429">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13430">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13431">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U13432">
<property type="protein sequence ID" value="AAC51347.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78027">
<property type="protein sequence ID" value="AAB64205.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314382">
<property type="protein sequence ID" value="BAG37008.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035422">
<property type="protein sequence ID" value="CAB55876.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC109079">
<property type="protein sequence ID" value="AAI09080.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC109080">
<property type="protein sequence ID" value="AAI09081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14482.1">
<molecule id="Q06187-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS76003.1">
<molecule id="Q06187-2"/>
</dbReference>
<dbReference type="PIR" id="I37212">
<property type="entry name" value="A45184"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000052.1">
<molecule id="Q06187-1"/>
<property type="nucleotide sequence ID" value="NM_000061.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001274273.1">
<molecule id="Q06187-2"/>
<property type="nucleotide sequence ID" value="NM_001287344.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001274274.1">
<property type="nucleotide sequence ID" value="NM_001287345.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.159494"/>
<dbReference type="UniGene" id="Hs.733206"/>
<dbReference type="PDB" id="1AWW">
<property type="method" value="NMR"/>
<property type="chains" value="A=212-275"/>
</dbReference>
<dbReference type="PDB" id="1AWX">
<property type="method" value="NMR"/>
<property type="chains" value="A=212-275"/>
</dbReference>
<dbReference type="PDB" id="1B55">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=2-170"/>
</dbReference>
<dbReference type="PDB" id="1BTK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=2-170"/>
</dbReference>
<dbReference type="PDB" id="1BWN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2-170"/>
</dbReference>
<dbReference type="PDB" id="1K2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=397-659"/>
</dbReference>
<dbReference type="PDB" id="1QLY">
<property type="method" value="NMR"/>
<property type="chains" value="A=216-273"/>
</dbReference>
<dbReference type="PDB" id="2GE9">
<property type="method" value="NMR"/>
<property type="chains" value="A=270-387"/>
</dbReference>
<dbReference type="PDB" id="2Z0P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/C/D=2-170"/>
</dbReference>
<dbReference type="PDB" id="3GEN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=382-659"/>
</dbReference>
<dbReference type="PDB" id="3K54">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A=382-659"/>
</dbReference>
<dbReference type="PDB" id="3OCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=393-656"/>
</dbReference>
<dbReference type="PDB" id="3OCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=393-656"/>
</dbReference>
<dbReference type="PDB" id="3P08">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=393-659"/>
</dbReference>
<dbReference type="PDB" id="3PIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="3PIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="3PIZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="3PJ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="3PJ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="3PJ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=387-659"/>
</dbReference>
<dbReference type="PDB" id="4NWM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/B=396-657"/>
</dbReference>
<dbReference type="PDB" id="4OT5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4OT6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4OTF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=393-657"/>
</dbReference>
<dbReference type="PDB" id="4OTQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4OTR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4RFY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4RFZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.17"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4RG0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=378-659"/>
</dbReference>
<dbReference type="PDB" id="4RX5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.36"/>
<property type="chains" value="A=393-657"/>
</dbReference>
<dbReference type="PDB" id="4YHF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=382-659"/>
</dbReference>
<dbReference type="PDB" id="4Z3V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=382-659"/>
</dbReference>
<dbReference type="PDB" id="4ZLY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=389-658"/>
</dbReference>
<dbReference type="PDB" id="4ZLZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=389-658"/>
</dbReference>
<dbReference type="PDB" id="5BPY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=396-659"/>
</dbReference>
<dbReference type="PDB" id="5BQ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.57"/>
<property type="chains" value="A=382-659"/>
</dbReference>
<dbReference type="PDB" id="5FBN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D=389-659"/>
</dbReference>
<dbReference type="PDB" id="5FBO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=389-659"/>
</dbReference>
<dbReference type="PDB" id="5JRS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B=396-659"/>
</dbReference>
<dbReference type="PDB" id="5KUP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.39"/>
<property type="chains" value="A=393-657"/>
</dbReference>
<dbReference type="PDB" id="5T18">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=396-659"/>
</dbReference>
<dbReference type="PDB" id="5U9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A=389-659"/>
</dbReference>
<dbReference type="PDBsum" id="1AWW"/>
<dbReference type="PDBsum" id="1AWX"/>
<dbReference type="PDBsum" id="1B55"/>
<dbReference type="PDBsum" id="1BTK"/>
<dbReference type="PDBsum" id="1BWN"/>
<dbReference type="PDBsum" id="1K2P"/>
<dbReference type="PDBsum" id="1QLY"/>
<dbReference type="PDBsum" id="2GE9"/>
<dbReference type="PDBsum" id="2Z0P"/>
<dbReference type="PDBsum" id="3GEN"/>
<dbReference type="PDBsum" id="3K54"/>
<dbReference type="PDBsum" id="3OCS"/>
<dbReference type="PDBsum" id="3OCT"/>
<dbReference type="PDBsum" id="3P08"/>
<dbReference type="PDBsum" id="3PIX"/>
<dbReference type="PDBsum" id="3PIY"/>
<dbReference type="PDBsum" id="3PIZ"/>
<dbReference type="PDBsum" id="3PJ1"/>
<dbReference type="PDBsum" id="3PJ2"/>
<dbReference type="PDBsum" id="3PJ3"/>
<dbReference type="PDBsum" id="4NWM"/>
<dbReference type="PDBsum" id="4OT5"/>
<dbReference type="PDBsum" id="4OT6"/>
<dbReference type="PDBsum" id="4OTF"/>
<dbReference type="PDBsum" id="4OTQ"/>
<dbReference type="PDBsum" id="4OTR"/>
<dbReference type="PDBsum" id="4RFY"/>
<dbReference type="PDBsum" id="4RFZ"/>
<dbReference type="PDBsum" id="4RG0"/>
<dbReference type="PDBsum" id="4RX5"/>
<dbReference type="PDBsum" id="4YHF"/>
<dbReference type="PDBsum" id="4Z3V"/>
<dbReference type="PDBsum" id="4ZLY"/>
<dbReference type="PDBsum" id="4ZLZ"/>
<dbReference type="PDBsum" id="5BPY"/>
<dbReference type="PDBsum" id="5BQ0"/>
<dbReference type="PDBsum" id="5FBN"/>
<dbReference type="PDBsum" id="5FBO"/>
<dbReference type="PDBsum" id="5JRS"/>
<dbReference type="PDBsum" id="5KUP"/>
<dbReference type="PDBsum" id="5T18"/>
<dbReference type="PDBsum" id="5U9D"/>
<dbReference type="ProteinModelPortal" id="Q06187"/>
<dbReference type="SMR" id="Q06187"/>
<dbReference type="BioGrid" id="107160">
<property type="interactions" value="79"/>
</dbReference>
<dbReference type="DIP" id="DIP-34071N"/>
<dbReference type="IntAct" id="Q06187">
<property type="interactions" value="49"/>
</dbReference>
<dbReference type="MINT" id="MINT-110243"/>
<dbReference type="STRING" id="9606.ENSP00000308176"/>
<dbReference type="BindingDB" id="Q06187"/>
<dbReference type="ChEMBL" id="CHEMBL5251"/>
<dbReference type="DrugBank" id="DB09053">
<property type="generic name" value="Ibrutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05204">
<property type="generic name" value="XL418"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1948"/>
<dbReference type="iPTMnet" id="Q06187"/>
<dbReference type="PhosphoSitePlus" id="Q06187"/>
<dbReference type="BioMuta" id="BTK"/>
<dbReference type="DMDM" id="547759"/>
<dbReference type="EPD" id="Q06187"/>
<dbReference type="MaxQB" id="Q06187"/>
<dbReference type="PaxDb" id="Q06187"/>
<dbReference type="PeptideAtlas" id="Q06187"/>
<dbReference type="PRIDE" id="Q06187"/>
<dbReference type="DNASU" id="695"/>
<dbReference type="Ensembl" id="ENST00000308731">
<molecule id="Q06187-1"/>
<property type="protein sequence ID" value="ENSP00000308176"/>
<property type="gene ID" value="ENSG00000010671"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621635">
<molecule id="Q06187-2"/>
<property type="protein sequence ID" value="ENSP00000483570"/>
<property type="gene ID" value="ENSG00000010671"/>
</dbReference>
<dbReference type="GeneID" id="695"/>
<dbReference type="KEGG" id="hsa:695"/>
<dbReference type="UCSC" id="uc004ehg.3">
<molecule id="Q06187-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="695"/>
<dbReference type="DisGeNET" id="695"/>
<dbReference type="GeneCards" id="BTK"/>
<dbReference type="GeneReviews" id="BTK"/>
<dbReference type="HGNC" id="HGNC:1133">
<property type="gene designation" value="BTK"/>
</dbReference>
<dbReference type="HPA" id="CAB016689"/>
<dbReference type="HPA" id="HPA001198"/>
<dbReference type="HPA" id="HPA002028"/>
<dbReference type="MalaCards" id="BTK"/>
<dbReference type="MIM" id="300300">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="300755">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="307200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06187"/>
<dbReference type="OpenTargets" id="ENSG00000010671"/>
<dbReference type="Orphanet" id="632">
<property type="disease" value="Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia"/>
</dbReference>
<dbReference type="Orphanet" id="47">
<property type="disease" value="X-linked agammaglobulinemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25454"/>
<dbReference type="eggNOG" id="KOG0197">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119011"/>
<dbReference type="HOGENOM" id="HOG000233859"/>
<dbReference type="HOVERGEN" id="HBG008761"/>
<dbReference type="InParanoid" id="Q06187"/>
<dbReference type="KO" id="K07370"/>
<dbReference type="OMA" id="ELGTGQF"/>
<dbReference type="OrthoDB" id="EOG091G0D46"/>
<dbReference type="PhylomeDB" id="Q06187"/>
<dbReference type="TreeFam" id="TF351634"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:Mal cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029482">
<property type="pathway name" value="Regulation of actin dynamics for phagocytic cup formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871809">
<property type="pathway name" value="FCERI mediated Ca+2 mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663213">
<property type="pathway name" value="RHO GTPases Activate WASPs and WAVEs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="Q06187"/>
<dbReference type="SIGNOR" id="Q06187"/>
<dbReference type="ChiTaRS" id="BTK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q06187"/>
<dbReference type="GeneWiki" id="Bruton%27s_tyrosine_kinase"/>
<dbReference type="GenomeRNAi" id="695"/>
<dbReference type="PRO" id="PR:Q06187"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000010671"/>
<dbReference type="CleanEx" id="HS_BTK"/>
<dbReference type="ExpressionAtlas" id="Q06187">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06187">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042629">
<property type="term" value="C:mast cell granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005547">
<property type="term" value="F:phosphatidylinositol-3,4,5-trisphosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042113">
<property type="term" value="P:B cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002344">
<property type="term" value="P:B cell affinity maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019722">
<property type="term" value="P:calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098761">
<property type="term" value="P:cellular response to interleukin-7"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071226">
<property type="term" value="P:cellular response to molecule of fungal origin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002553">
<property type="term" value="P:histamine secretion by mast cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0007498">
<property type="term" value="P:mesoderm development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001818">
<property type="term" value="P:negative regulation of cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0045579">
<property type="term" value="P:positive regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001812">
<property type="term" value="P:positive regulation of type I hypersensitivity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001805">
<property type="term" value="P:positive regulation of type III hypersensitivity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0002902">
<property type="term" value="P:regulation of B cell apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002721">
<property type="term" value="P:regulation of B cell cytokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001562">
<property type="entry name" value="Znf_Btk_motif"/>
</dbReference>
<dbReference type="Pfam" id="PF00779">
<property type="entry name" value="BTK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00452">
<property type="entry name" value="SH3DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00402">
<property type="entry name" value="TECBTKDOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00107">
<property type="entry name" value="BTK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51113">
<property type="entry name" value="ZF_BTK"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="14 74">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Tyrosine-protein kinase BTK" id="PRO_0000088065">
<location>
<begin position="2"/>
<end position="659"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="16">
<location>
<begin position="3"/>
<end position="133"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="19">
<location>
<begin position="214"/>
<end position="274"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="18">
<location>
<begin position="281"/>
<end position="377"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="17">
<location>
<begin position="402"/>
<end position="655"/>
</location>
</feature>
<feature type="zinc finger region" description="Btk-type" evidence="20">
<location>
<begin position="135"/>
<end position="171"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="17">
<location>
<begin position="408"/>
<end position="416"/>
</location>
</feature>
<feature type="region of interest" description="Inositol-(1,3,4,5)-tetrakisphosphate 1-binding">
<location>
<begin position="12"/>
<end position="24"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor-binding">
<location>
<begin position="474"/>
<end position="479"/>
</location>
</feature>
<feature type="short sequence motif" description="CAV1-binding">
<location>
<begin position="581"/>
<end position="588"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="17 21">
<location>
<position position="521"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="22 68 76">
<location>
<position position="143"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="22 68 76">
<location>
<position position="154"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="22 68 76">
<location>
<position position="155"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="22 68 76">
<location>
<position position="165"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate" evidence="22">
<location>
<position position="26"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate" evidence="22">
<location>
<position position="28"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate" evidence="22">
<location>
<position position="39"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate; via carbonyl oxygen" evidence="22">
<location>
<position position="53"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="17">
<location>
<position position="430"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="42 75 76">
<location>
<position position="445"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="42 75 76">
<location>
<position position="461"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="42 75 76">
<location>
<position position="477"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="42 75 76">
<location>
<position position="538"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen" evidence="42 75 76">
<location>
<position position="539"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via carbonyl oxygen" evidence="42 75 76">
<location>
<position position="542"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="14 74">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="15">
<location>
<position position="40"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="115"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCB" evidence="29">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 13">
<location>
<position position="191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="13 32 39 61 66">
<location>
<position position="223"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="15">
<location>
<position position="344"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="361"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by LYN and SYK" evidence="61 66">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="604"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="33">
<location>
<position position="617"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33">
<location>
<position position="623"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="659"/>
</location>
</feature>
<feature type="splice variant" description="In isoform BTK-C." id="VSP_053838" evidence="77">
<original>M</original>
<variation>MASWSIQQMVIGCPLCGRHCSGGEHTGELQKEEAM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006216">
<original>L</original>
<variation>P</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006217" evidence="63">
<original>K</original>
<variation>R</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006218">
<original>S</original>
<variation>F</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008291" evidence="71">
<original>K</original>
<variation>E</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006219" evidence="49">
<original>F</original>
<variation>S</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008292">
<original>K</original>
<variation>R</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; no effect on phosphorylation of GTF2I." id="VAR_008293">
<original>R</original>
<variation>C</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; moderate; dbSNP:rs128620185." id="VAR_006220" evidence="53 58 71">
<original>R</original>
<variation>H</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006221" evidence="63">
<original>R</original>
<variation>P</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe; dbSNP:rs128620189." id="VAR_006222" evidence="48 53">
<original>T</original>
<variation>P</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008960" evidence="26">
<original>Y</original>
<variation>S</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008294">
<original>Y</original>
<variation>C</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008295">
<original>Y</original>
<variation>N</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008296" evidence="71">
<original>I</original>
<variation>N</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008297">
<original>V</original>
<variation>D</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006223" evidence="51">
<original>V</original>
<variation>F</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56035945." id="VAR_041676" evidence="38">
<original>R</original>
<variation>K</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006224">
<original>Q</original>
<variation>QSVFSSTR</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621190." id="VAR_006225" evidence="52">
<original>V</original>
<variation>D</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008298">
<original>S</original>
<variation>F</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008299" evidence="71">
<original>T</original>
<variation>P</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008300" evidence="71">
<original>Q</original>
<variation>H</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008301" evidence="70">
<original>C</original>
<variation>S</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008302">
<original>C</original>
<variation>G</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008303" evidence="70 71">
<original>C</original>
<variation>R</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008304">
<original>T</original>
<variation>P</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung large cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions." id="VAR_041677" evidence="38">
<original>P</original>
<variation>K</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe." id="VAR_006226" evidence="53">
<location>
<begin position="260"/>
<end position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008305" evidence="72">
<original>R</original>
<variation>Q</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621194." id="VAR_006227" evidence="49 58 59 65">
<original>R</original>
<variation>W</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006228" evidence="64 71">
<original>L</original>
<variation>P</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006230" evidence="46 63">
<original>G</original>
<variation>E</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008306">
<original>G</original>
<variation>R</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006229" evidence="48">
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; loss of activity; dbSNP:rs128621195." id="VAR_006231" evidence="59">
<original>R</original>
<variation>G</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008307" evidence="72">
<original>R</original>
<variation>T</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008308">
<original>D</original>
<variation>E</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; moderate." id="VAR_008309">
<original>V</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621196." id="VAR_006232" evidence="54">
<original>Y</original>
<variation>S</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006233" evidence="55">
<original>L</original>
<variation>F</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; mild; dbSNP:rs28935478." id="VAR_006234" evidence="52">
<original>Y</original>
<variation>C</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006235">
<original>H</original>
<variation>Q</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006236">
<original>H</original>
<variation>P</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006237">
<original>N</original>
<variation>Y</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008310">
<original>S</original>
<variation>F</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008311" evidence="71">
<original>L</original>
<variation>F</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006238" evidence="49">
<original>I</original>
<variation>M</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008312" evidence="71">
<original>R</original>
<variation>G</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; moderate; dbSNP:rs128621198." id="VAR_006239" evidence="53">
<original>L</original>
<variation>P</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008313" evidence="71">
<original>G</original>
<variation>R</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs144079566." id="VAR_006240">
<original>Y</original>
<variation>H</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006241" evidence="62">
<original>I</original>
<variation>N</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; loss of phosphorylation of GTF2I; dbSNP:rs128620184." id="VAR_006242" evidence="50">
<original>K</original>
<variation>E</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008314" evidence="72">
<original>K</original>
<variation>R</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008315" evidence="72">
<original>E</original>
<variation>D</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008316">
<original>G</original>
<variation>D</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008317">
<original>G</original>
<variation>V</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006243" evidence="46">
<original>Y</original>
<variation>D</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006244" evidence="62">
<original>M</original>
<variation>R</variation>
<location>
<position position="477"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with chronic lymphocytic leukemia; unknown pathological significance; results in resistance to ibrutinib therapy; results in a protein that is reversibly inhibited by ibrutinib; disrupts the covalent binding between the enzyme and ibrutinib." id="VAR_074309" evidence="43 44 45">
<original>C</original>
<variation>S</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006245">
<original>C</original>
<variation>F</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs41310709." id="VAR_006246" evidence="63">
<original>C</original>
<variation>W</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621200." id="VAR_006247" evidence="54">
<original>C</original>
<variation>R</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006248" evidence="71">
<original>C</original>
<variation>Y</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008318">
<original>A</original>
<variation>D</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008319">
<original>M</original>
<variation>I</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006249" evidence="49">
<original>M</original>
<variation>V</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008961" evidence="26">
<original>L</original>
<variation>P</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008962" evidence="26">
<original>L</original>
<variation>Q</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008320">
<original>L</original>
<variation>R</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe; prevents activation due to absence of contact between the catalytic loop and the regulatory phosphorylated residue; dbSNP:rs128621202." id="VAR_006251" evidence="48 50 52 54">
<original>R</original>
<variation>Q</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008321" evidence="71">
<original>D</original>
<variation>G</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe." id="VAR_006252" evidence="63">
<original>D</original>
<variation>H</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe." id="VAR_006253">
<original>D</original>
<variation>N</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008322">
<original>A</original>
<variation>E</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008323" evidence="72">
<original>R</original>
<variation>G</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006254" evidence="49">
<original>R</original>
<variation>P</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe; disturbs ATP-binding; dbSNP:rs128620183." id="VAR_006255" evidence="50 71">
<original>R</original>
<variation>Q</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006256" evidence="49">
<original>N</original>
<variation>K</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008324" evidence="72">
<original>V</original>
<variation>F</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; growth hormone deficiency; dbSNP:rs128621203." id="VAR_006257" evidence="52">
<original>L</original>
<variation>P</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008963" evidence="26">
<original>R</original>
<variation>G</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006258" evidence="65">
<original>R</original>
<variation>K</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008325" evidence="71">
<original>F</original>
<variation>S</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs28935176." id="VAR_006259" evidence="27 50">
<original>R</original>
<variation>P</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621204." id="VAR_006260" evidence="49 52 54 71">
<original>R</original>
<variation>W</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008326" evidence="72">
<original>W</original>
<variation>L</variation>
<location>
<position position="563"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe." id="VAR_006261" evidence="47">
<original>E</original>
<variation>K</variation>
<location>
<position position="567"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008964" evidence="26">
<original>S</original>
<variation>Y</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621205." id="VAR_006262">
<original>W</original>
<variation>R</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006263" evidence="49 50">
<original>A</original>
<variation>V</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008327">
<original>F</original>
<variation>S</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; mild." id="VAR_006264" evidence="47">
<original>M</original>
<variation>L</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008328">
<original>E</original>
<variation>D</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; moderate; interferes with substrate binding; dbSNP:rs128621206." id="VAR_006265" evidence="50 53">
<original>E</original>
<variation>G</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008965" evidence="26">
<original>E</original>
<variation>K</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006267" evidence="65">
<original>S</original>
<variation>P</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; mild; interferes with substrate binding." id="VAR_006268" evidence="50 71">
<original>G</original>
<variation>E</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006269" evidence="49">
<original>G</original>
<variation>R</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006270">
<original>Y</original>
<variation>C</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; mild; dbSNP:rs128621208." id="VAR_006271" evidence="59">
<original>A</original>
<variation>D</variation>
<location>
<position position="607"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; mild; interferes with substrate binding and/or domain interactions; dbSNP:rs128621209." id="VAR_006272" evidence="50 53">
<original>G</original>
<variation>D</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008330">
<original>P</original>
<variation>A</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006273">
<original>P</original>
<variation>S</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008331" evidence="71">
<original>P</original>
<variation>T</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008332" evidence="72">
<original>A</original>
<variation>P</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008333" evidence="71">
<original>V</original>
<variation>G</variation>
<location>
<position position="626"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism, 35%." id="VAR_006274">
<original>M</original>
<variation>I</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128621210." id="VAR_006275" evidence="52 54">
<original>M</original>
<variation>K</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008334">
<original>M</original>
<variation>T</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006276" evidence="63">
<original>C</original>
<variation>Y</variation>
<location>
<position position="633"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006277" evidence="48">
<original>R</original>
<variation>C</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; severe." id="VAR_006278" evidence="47 71">
<original>R</original>
<variation>H</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_008335">
<original>F</original>
<variation>L</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006279" evidence="63">
<original>F</original>
<variation>S</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA." id="VAR_006280">
<original>L</original>
<variation>P</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="sequence variant" description="In XLA; dbSNP:rs128622212." id="VAR_006281" evidence="52">
<original>L</original>
<variation>P</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation of GTF2I." evidence="66">
<original>E</original>
<variation>K</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation of GTF2I." evidence="66">
<original>P</original>
<variation>A</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation of GTF2I." evidence="61 66">
<original>Y</original>
<variation>F</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Large decrease in binding by SH3BP5." evidence="73">
<original>WW</original>
<variation>LL</variation>
<location>
<begin position="251"/>
<end position="252"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation of GTF2I." evidence="66">
<original>W</original>
<variation>L</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation of GTF2I." evidence="66">
<original>R</original>
<variation>K</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation of GTF2I." evidence="66">
<original>Y</original>
<variation>F</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defective in mediating calcium response." evidence="33">
<original>Y</original>
<variation>E</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAG37008." ref="7" evidence="77">
<original>R</original>
<variation>K</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="6"/>
<end position="13"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="18"/>
<end position="20"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="25"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="43"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="48"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="61"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="93"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="100"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="111"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="118"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="149"/>
<end position="152"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="153"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="165"/>
<end position="167"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="228"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="248"/>
<end position="252"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="257"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="261"/>
<end position="265"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="279"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="288"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="303"/>
<end position="308"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="315"/>
<end position="326"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="330"/>
<end position="335"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="343"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="350"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="355"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="373"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="393"/>
<end position="395"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="399"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="402"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="414"/>
<end position="421"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="425"/>
<end position="431"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="434"/>
<end position="436"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="439"/>
<end position="450"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="460"/>
<end position="464"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="466"/>
<end position="469"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="471"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="482"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="489"/>
<end position="491"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="495"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="524"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="527"/>
<end position="529"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="542"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="549"/>
<end position="552"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="554"/>
<end position="556"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="561"/>
<end position="563"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="566"/>
<end position="571"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="576"/>
<end position="591"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="592"/>
<end position="594"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="597"/>
<end position="600"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="603"/>
<end position="611"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="624"/>
<end position="632"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="638"/>
<end position="640"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="644"/>
<end position="657"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AWW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AWX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BTK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QLY"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GE9"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z0P"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PIX"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PJ2"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RFZ"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FBO"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5U9D"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35991"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00432"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10196129"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10196179"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10220140"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10339589"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10612838"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10678660"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11577348"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11598012"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11606584"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751885"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12573241"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15375214"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16415872"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16517732"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16644721"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16738337"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17932028"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807924"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20052711"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21280133"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24869597"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24869598"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25189416"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7627183"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633420"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633429"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7711734"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7809124"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7849006"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7849697"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7849721"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7880320"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7897635"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8013627"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8070576"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8162018"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8162056"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8594569"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8630736"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8634718"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8695804"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723128"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8834236"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9012831"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9016530"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9218782"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9260159"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9280283"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9445504"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9545398"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9571151"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="46"/>
</evidence>
<evidence key="76" type="ECO:0000269">
<source ref="47"/>
</evidence>
<evidence key="77" type="ECO:0000305"/>
<sequence length="659" mass="76281" checksum="DF06B5D1FEC257CC" modified="2007-01-23" version="3">
MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEK
ITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEEL
RKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSS
HRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDE
YFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGK
EGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELIN
YHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK
WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG
CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF
GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER
FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>